Category: Events

We kicked off the year with more trade shows! From January 26 to 29, INVES BIOFARM participated in the 3rd edition of COSMOPROF NORTH AMERICA MIAMI.

Over four days, the event brought together more than 800 brands and suppliers from the global cosmetics and personal care industry. It provided us with an excellent opportunity to showcase INVES BIOFARM’s latest developments and services.

It was an honor to meet with industry professionals, distributors, manufacturers, and experts, explore new business opportunities, and discover the latest innovations in beauty products and technologies. The outstanding reception of our third-party manufacturing services further strengthens our expansion strategy across the American continent.

At INVES BIOFARM, we highly value this experience and would like to thank the Cosmoprof North America organization, ICEX, and all the professionals who visited our booth to learn more about our science applied to skin care. We return home with great motivation and exciting projects that will soon come to life.

This past December, Inves Biofarm attended the prestigious Jio World Convention Centre in Mumbai to participate in the 6th edition of Cosmoprof India. This event has established itself as an essential gathering for beauty professionals, both within the strategic Indian market and on an international scale.
From our booth, we showcased our latest innovations in the dermo-cosmetic sector, where the main highlight was our GF STABILIZING PATENT. The excellent reception of our Contract Development and Manufacturing Services (CDMO) and our INVESKIN product line reinforces our expansion strategy across the Asian continent.
We would like to extend our gratitude to the organizers, ICEX, and Cosmoprof India, as well as to all the professionals who visited our stand to learn more about our science-based approach to skincare.

This year, we were delighted to once again celebrate our participation in Cosmoprof Asia, one of the most important international gatherings in the cosmetics sector.

The fair was a great catalyst for new ideas. We gained insights into the latest trends in ingredients, formulation, sustainability, and product innovation. It was also fundamental for strengthening relationships with partners and colleagues from all over the world.

We return with the energy and inspiration needed to drive new projects forward.

Thank you to everyone we connected with for making this such a valuable experience. We are back with many projects that will soon be revealed!

We are thrilled to share the success of our participation in MEDICA Düsseldorf, one of the world’s most significant events for medical technology and healthcare solutions.

For Inves Biofarm, it was a key opportunity to:

Connect with leading professionals in the healthcare sector.

Discover the latest trends that are shaping the future of health.

Explore strategic collaborations that will drive innovation across our product lines.

A huge thank you to FENIN for their excellent support and organization, and to everyone who visited our booth! We continue our dedication to developing solutions that improve health and foster greater technological advancement.

INVES BIOFARM expresses its great enthusiasm and satisfaction following its recent successful participation at BIOSPAIN 2025, the most important biotechnology event in Spain, held in Barcelona from October 7th to 9th.

Our attendance was made possible with the invaluable support of Andalucía TRADE, to whom we extend our deepest gratitude for their assistance.

BIOSPAIN 2025 served as the ideal platform to:

Share our most recent projects in biotechnology applied to skin care.

Explore new synergies and collaboration opportunities with industry leaders, investors, and international experts.

Strengthen our network within the global biotechnology ecosystem.

INVES BIOFARM’s presence at BIOSPAIN 2025 reaffirms our strong commitment to scientific innovation and our desire to remain at the forefront of developing advanced dermatological solutions.

INVES BIOFARM attended FARMAFORUM on September 17th and 18th, the most significant gathering for the Pharmaceutical Industry in Spain.

We sincerely thank the organizers for the excellent execution of the event. The two-day conference served as the nerve center for debate and learning around the Biotechnology and Cosmetics industries, as well as the field of medical devices. This was a fundamental event for sharing knowledge and establishing new strategic collaborations.

The INVES BIOFARM research team is proud to announce our involvement in another project of excellence in innovation.

Our primary goal is the development of a highly effective and safe product for the treatment of knee joint lesions (or articular injuries). We aim to address osteoarticular pathologies through an innovative solution that offers regenerative benefits.

The core of this innovation lies in the implementation of an advanced encapsulation method to incorporate new technologies into the final formulation. This approach guarantees the stability, efficacy, and controlled release of the active principles, thereby maximizing their therapeutic potential.

The project is supported by a high-level scientific and technological consortium, composed of:

Inves Biofarm (Coordinator) Leitat (Technological Center) VHIR (Vall d’Hebron Research Institute)

This collaboration is based on a long and fruitful track record of joint success, ensuring the integration of expertise in research, technological development, and clinical application.

The INVES BIOFARM team is currently carrying out the VAGINEF project in collaboration with Leitat and the Vall d’Hebron Hospital in Barcelona.

The central goal of the project is the development of an effective and safe topical product designed for the treatment of vaginal atrophy. This development seeks to significantly improve the quality of life for women suffering from this condition.

The crucial technological innovation lies in the use of a protein stabilization technology patented by the company. This method allows the protein activity to be preserved intact for a longer period, thereby ensuring maximum efficacy.

The project benefits from the multidisciplinary expertise of its collaborators:

INVES BIOFARM, Providing the stabilization technology and project coordination.

Leitat, A key technological center and Vall d’Hebron Hospital in Barcelona, Guaranteeing clinical validation and the practical application of the research.

We are now halfway through the CRONISAN project, which aims to develop an effective formulation incorporating growth factors for treating chronic ulcers. These growth factors will be stabilised using a stabilisation patent to guarantee their effectiveness over time.

The consortium comprises Inves Biofarm (the coordinator), UGR and Leitat, with whom we have a long and successful history of collaboration.

This project forms part of the PCPP2022 programme and has been funded under reference CPP2022-009544 by MICIU/AEI/10.13039/501100011033 and by the European Union “NextGenerationEU”/PRTR.

Instituto de Investigación Biotecnológica, Farmacéutica y Medicamentos Huérfanos, S.L. has benefited from the Mentoring and Support Programme for the Internationalisation of SMEs. The company has used these funds to co-finance dissemination and promotional materials, specifically for the stand at the 2024 BeautyWorld Middle East fair. The Middle East region is a dynamic market for the beauty and wellness industry and a prime destination for growth and innovation. Thanks to this programme, we have had the opportunity to network with some of the industry’s top leaders and expand our existing contacts in the region.